ArticleClinical case reports2025

Osimertinib as Salvage Therapy in Advanced Non-Small Cell Lung Cancer After Aumolertinib Resistance With T790M Mutation: A Case Report.

Yongtong Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.